Trial intelligence / Profile preview

Comparison of quality of recovery and analgesic effect between remimazolam and desflurane during laparoscopic cholecystectomy

KCT0008688Phase 4Not yet recruiting

Sponsor
Hana Pharm
Start
Aug 2023
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial in gallbladder disease comparing Remimazolam anesthesia with Desflurane anesthesia (2 arms). Primary endpoints: Quality of recovery and Analgesic effect. Planned start Aug 2023; status: not yet recruiting.

02

Drugs

remimazolamdesflurane
03

Conditions

gallbladder disease

Beyond the preview

Go deeper on KCT0008688.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0008688.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call